News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Shannon Matheny

Articles by Shannon Matheny

29 ELEVATE: A Phase 1b/2, Open-Label, Umbrella Study Evaluating Elacestrant in Various Combinations in Patients (pts) With Estrogen Receptor–Positive (ER+), HER2-Negative (HER2–) Locally Advanced or Metastatic Breast Cancer (mBC)

29 ELEVATE: A Phase 1b/2, Open-Label, Umbrella Study Evaluating Elacestrant in Various Combinations in Patients (pts) With Estrogen Receptor–Positive (ER+), HER2-Negative (HER2–) Locally Advanced or Metastatic Breast Cancer (mBC)

ByHope S. Rugo, MD,Aditya Bardia, MD, MPH, FASCO,Erika P. Hamilton, MD,Sara A. Hurvitz, MD,Sara M. Tolaney, MD, MPH,Virginia Kaklamani, MD, DSc,Paula Muñoz Romero,Shannon Matheny,Kathy Puyana Theall,Joyce A. O’Shaughnessy

July 21st 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Durvalumab Plus FLOT in Resectable Gastric/GEJ Cancers

Novel Bispecific ADC Earns FDA Fast Track Status in Urothelial Cancer

EU Approves Liso-Cel in R/R MCL With ≥ 2 Prior Lines of Systemic Therapy

Temferon Yields Preliminary Survival in Newly Diagnosed Glioblastoma Trial

Does Increased Infiltration Reporting Correlate with Better Outcomes?

© 2025 MJH Life Sciences^®

All rights reserved.